Population-attributable estimates for risk factors associated with hepatitis B and C: policy implications for Pakistan and other South Asian countries

[1] Te HS(2010)Epidemiology of hepatitis B and C viruses: a global overview Clin Liver Dis 14 1-21

[2] Jensen DM(2002)Is severe liver disease a common outcome for people with chronic hepatitis C? J Gastroenterol Hepatol 17 423-430

[3] Dore GJ(2006)The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J Hepatol 45 529-538

[4] Freeman AJ(2004)Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures J Viral Hepat 11 97-107

[5] Law M(2010)At last a global response to viral hepatitis Bull World Health Organ 88 801-802

[6] Kaldor JM(2009)Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors Int J Infect Dis 13 9-19

[7] Perz JF(2004)Global burden of disease (GBD) for hepatitis C J Clin Pharmacol 44 20-29

[8] Armstrong GL(2011)Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews The Lancet 378 571-583

[9] Farrington LA(2010)Changing trend of viral hepatitis—“A twenty one year report from Pakistan Medical Research Council Research Centre, Jinnah Postgraduate Medical Centre, Karachi” J Pak Med Assoc 61 86-89

[10] Hutin YJF(2010)Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures East Mediterr Health J 16 S15-S23

[1] Te HS(2010)Epidemiology of hepatitis B and C viruses: a global overview Clin Liver Dis 14 1-21

[2] Jensen DM(2002)Is severe liver disease a common outcome for people with chronic hepatitis C? J Gastroenterol Hepatol 17 423-430

[3] Dore GJ(2006)The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J Hepatol 45 529-538

[4] Freeman AJ(2004)Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures J Viral Hepat 11 97-107

[5] Law M(2010)At last a global response to viral hepatitis Bull World Health Organ 88 801-802

[6] Kaldor JM(2009)Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors Int J Infect Dis 13 9-19

[7] Perz JF(2004)Global burden of disease (GBD) for hepatitis C J Clin Pharmacol 44 20-29

[8] Armstrong GL(2011)Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews The Lancet 378 571-583

[9] Farrington LA(2010)Changing trend of viral hepatitis—“A twenty one year report from Pakistan Medical Research Council Research Centre, Jinnah Postgraduate Medical Centre, Karachi” J Pak Med Assoc 61 86-89

[10] Hutin YJF(2010)Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures East Mediterr Health J 16 S15-S23